Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-18-017592
Filing Date
2018-06-21
Accepted
2018-06-21 16:30:28
Documents
1
Period of Report
2018-06-20

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3061
  Complete submission text file 0000899243-18-017592.txt   4719
Mailing Address 11055 FLINTKOTE AVENUE SAN DIEGO CA 92121
Business Address 11055 FLINTKOTE AVENUE SAN DIEGO CA 92121 858-217-5420
Trovagene, Inc. (Issuer) CIK: 0001213037 (see all company filings)

EIN.: 043721895 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O UNIVERSITY OF NEBR MEDICAL CENTER 983135 NEBRASKA MEDICAL CENTER OMAHA NE 68198-3135
Business Address
Markin Rodney S (Reporting) CIK: 0001393415 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35558 | Film No.: 18912107